De Oliva-Neto et al., 2016 - Google Patents
Yeasts as potential source for prebiotic β-glucan: Role in human nutrition and healthDe Oliva-Neto et al., 2016
View HTML- Document ID
- 11139898940115838454
- Author
- De Oliva-Neto P
- Oliveira S
- Zilioli E
- Bellini M
- Publication year
- Publication venue
- Probiotics and prebiotics in human nutrition and health
External Links
Snippet
Yeasts are a potential source for prebiotic β-glucans. This polysaccharide is characterized by d-glucose monomers linked by β-glycosidic bonds. There are significant structural differences in β-glucans depending on the source and method in which they are obtaining …
- 229920002498 Beta-glucan 0 title abstract description 117
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mirończuk-Chodakowska et al. | Beta-glucans from fungi: Biological and health-promoting potential in the COVID-19 pandemic era | |
| Lu et al. | Macrofungi: A review of cultivation strategies, bioactivity, and application of mushrooms | |
| Jayachandran et al. | A critical review on the impacts of β-glucans on gut microbiota and human health | |
| Borchani et al. | Structural characterization, technological functionality, and physiological aspects of fungal β-D-glucans: a review | |
| Rahar et al. | Preparation, characterization, and biological properties of β-glucans | |
| Kaur et al. | Structural features, modification, and functionalities of beta-glucan | |
| Chaudhari et al. | Therapeutic and industrial applications of curdlan with overview on its recent patents | |
| Stier et al. | Immune-modulatory effects of dietary Yeast Beta-1, 3/1, 6-D-glucan | |
| Bandara | A review of the polysaccharide, protein and selected nutrient content of Auricularia, and their potential pharmacological value | |
| Giavasis | Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals | |
| Singla et al. | Beta-glucan as a soluble dietary fiber source: Origins, biosynthesis, extraction, purification, structural characteristics, bioavailability, biofunctional attributes, industrial utilization, and global trade | |
| Samuelsen et al. | Effects of orally administered yeast‐derived beta‐glucans: A review | |
| Mantovani et al. | β-Glucans in promoting health: Prevention against mutation and cancer | |
| Rop et al. | Beta-glucans in higher fungi and their health effects | |
| EP2370475B1 (en) | Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells | |
| Chioru et al. | β-Glucans: characterization, extraction methods, and valorization | |
| US20070231449A1 (en) | Non-starchy rice bran polysaccharides | |
| Sushytskyi et al. | Perspectives in the application of high, medium, and low molecular weight oat β-d-Glucans in dietary nutrition and food technology—a short overview | |
| Javmen et al. | β-Glucan from Saccharomyces cerevisiae induces IFN-γ production in vivo in BALB/c mice | |
| Lee et al. | Immunostimulatory and anti-metastatic activity of polysaccharides isolated from byproducts of the corn starch industry | |
| Jo et al. | Polysaccharide isolated from fermented barley activates innate immune system and anti-tumor metastasis in mice | |
| Bulam et al. | β-Glucans: An important bioactive molecule of edible and medicinal mushrooms | |
| Flores et al. | The glucans mushrooms: molecules of significant biological and medicinal value | |
| Selvasekaran et al. | Fungal exopolysaccharides: production and biotechnological industrial applications in food and allied sectors | |
| Srivastava et al. | Nutraceutical products based on polysaccharides: sources, properties and applications |